In fact, one paper Mercola cites, which noted a 71% increase in the prevalence of 19A, also said there had been a dramatic 44% reduction in invasive pneumococcal disease, including pneumonia, meningitis, and bloodstream infections and that includes the increase in 19A. The new vaccine, Prevnar 13, introduced in 2010, protects against the deadly 19A strain, which now appears to be on the wane.

FORBES: A Vaccine Eliminated A Deadly Killer Of Infants. So Why Do Some People Fear It?

But in 2000 Wyeth scored a huge hit with Prevnar, the first vaccine for infants against pneumococcal bacteria, a common cause of pneumonia and ear infections.

FORBES: Magazine Article

The donor commitments provide manufacturers with an incentive to build manufacturing capacity to produce the pneumococcal vaccine, which protects children against the leading cause of pneumonia, which in turn is the leading cause of death for children under age 5.

FORBES: GAVI Alliance CEO: Leadership Is About Vision and Responsibility, Not Power

The pneumococcal vaccine, made by Pfizer, has resulted in dramatic drops in meningitis and pneumonia.

FORBES: How Vaccines Have Changed Our World In One Graphic

But that may not be the case with Prevnar 13, a new pneumococcal 13-valent conjugate vaccine for older people (ages 50 and up) to prevent pneumonia.

FORBES: The Government Is Dragging Its Feet on New Vaccines